Skip to main content
Black Friday Sale - Get 40% off Vantage
Published loading...Updated

Precipitation Offers Low-Cost Solution for Monoclonal Manufacturing

Precipitation-based purification could help make therapeutic mAbs more accessible, according to the Gates Foundation, which has awarded $3.1 million to a team using the approach as part of an effort to cut the cost of such drugs to $10 per gram. The grant will support scientists at Rensselaer Polytechnic Institute (RPI) in New York who are working on a low-cost alternative to the affinity-based purification methods used in the production of mono…

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

GEN - Genetic Engineering and Biotechnology News… broke the news in on Tuesday, November 25, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal